Apellis Pharmaceuticals, Inc.
← Back to APLS Overview

Apellis Pharmaceuticals, Inc. (APLS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-13.43

Financial Fundamentals

APLSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2014-03-31-5.71
2014-06-30-5.71
2014-09-30-6.51
2014-12-31-23.60
2015-03-31-17.85
2015-06-30-17.85
2015-09-30-2.03
2015-12-31-7.72
2016-03-31-9.55
2016-06-30-9.55
2016-09-30-8.80
2016-12-31-9.59
2017-03-31-7.01
2017-06-30-5.23
2017-09-30-10.37
2017-12-31-10.17
2018-03-31-12.81
2018-06-30-9.02
2018-09-30-6.82
2018-12-31-5.09
2019-03-31-5.58
2019-06-30-5.66
2019-09-30-5.50
2019-12-31-4.98
2020-03-31-2.92
2020-06-30-5.20
2020-09-30-4.20
2020-12-3113.86
2021-03-31-4.63
2021-06-30-5.81
2021-09-30-3.61
2021-12-31-6.84
2022-03-31-8.95
2022-06-30-7.73
2022-09-30-9.74
2022-12-31-8.62
2023-03-31-10.56
2023-06-30-22.27
2023-09-30-8.16
2023-12-31-20.48
2024-03-31-27.63
2024-06-30-29.85
2024-09-30-15.55
2024-12-31-27.19
2025-03-31-7.44
2025-06-30-12.94
2025-09-303.31
2025-12-31-13.43

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.